CUSTOMER SUPPORT
  • Home
  • Investor
  • Company Information

INVESTOR

Company Information

4DMedical is an Australian-based medical technology company, commercialising four-dimensional lung imaging solutions.

4DMedical was incorporated in 2012 to acquire imaging platform, XV Technology™, and associated intellectual property, from Monash University where it was originally conceived in 2005 and developed by CEO, Andreas Fouras, and his former research group.
4DMedical’s XV Technology™ is the first FDA cleared respiratory imaging solution that utilises mathematical models and algorithms to convert sequences of X-ray images into four-dimensional quantitative data. XV Technology™ is the result of over 15 years of development and published preclinical and clinical studies. The technology has been extensively patented, with core patents granted in key jurisdictions including the United States and Australia.
4DMedical considers its market opportunity to be supplementing or replacing existing respiratory diagnostic modalities. In 2019, more than US$31 billion was spent on respiratory diagnostics across more than 377 million procedures globally.

Announcements

Investor Fact Sheet

Name:
4DMedical Limited
Incorporated:
December 2012
Business Description:
4DMedical is a medical technology company based in Melbourne, Australia, established to commercialise four-dimensional lung imaging platform, XV Technology™
LISTINGS:
4DMedical Limited (4DX) is listed on:The Australian Securities Exchange (ASX) Its securities are listed under ASX code: 4DX
Registered Office:

‘Melbourne Connect’
Level 7/700 Swanston StreetCarlton VIC 3053
Telephone: +61 3 9545 5940

Website:

www.4dmedical.com

Auditor:
PKF Melbourne Audit & Assurance Pty Ltd Level 12, 440 Collins Street Melbourne VIC 3000
Board of Directors:

Dr Robert A. Figlin
Non-Executive Director

Professor Christine Jenkins
Non-Executive Director

Mr John Livingston
Non-Executive Director

Mr Julian Sutton
Executive Chair

Dr Geraldine McGinty
Non-Executive Director

Dr Andreas Fouras
Managing Director & CEO

Company Secretary:

companysecretary@4dmedical.com

Investor Relations:

investor.relations@4dmedical.com

Share Registry:

Australia
MUFG Corporate Markets (AU) LimitedLevel 12, 680 George Street
Sydney NSW 2000 Telephone: 1300 554 474 (within Australia)
+61 1300 554 474 (outside Australia)

CUSTOMER SUPPORT